Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Anal squamous intraepithelial lesions: an update and proposed management algorithm

Abstract

The term anal squamous intraepithelial lesion (ASIL) is used to describe premalignant change of anal squamous cells that precede the development of squamous cell carcinoma. Pathophysiology is driven by the human papilloma virus (HPV), and progression and regression of ASIL being well described, with 12% of high-grade lesions progressing to invasive cancer within 5 years. Vaccination against HPV is effective for primary prevention. Management consists of identification and treatment of high-grade lesions to prevent progression to squamous cell carcinoma. Management of established ASIL aims to avoid the progression to invasive cancer and maintain fecal continence. A combination of surveillance, excision, ablative, or topical therapies is used to achieve this. The aim of the present study was to review the contemporary evidence about ASIL and to suggest a management algorithm.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA (2006) Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 76(8):715–717. https://doi.org/10.1111/j.1445-2197.2006.03837.x

  2. 2.

    Sykes P, Smith N, McCormick P, Frizelle FA (2002) High-grade vulval intraepithelial neoplasia (VIN 3): a retrospective analysis of patient characteristics, management, outcome and relationship to squamous cell carcinoma of the vulva 1989-1999. Aust N Z J Obstet Gynaecol 42(1):69–74

  3. 3.

    Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12(2):186–192

  4. 4.

    Carter PS, Sheffield JP, Shepherd N, Melcher DH, Jenkins D, Ewings P, Talbot I, Northover JM (1994) Interobserver variation in the reporting of the histopathological grading of anal intraepithelial neoplasia. J Clin Pathol 47(11):1032–1034

  5. 5.

    Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC (2013) The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 32(1):76–115. https://doi.org/10.1097/PGP.0b013e31826916c7

  6. 6.

    Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, Markowitz LE (2011) Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 204(4):566–573. https://doi.org/10.1093/infdis/jir341

  7. 7.

    IARC (2007) Monographs on the evaluation of carcinogenic risks to humans, Human Papillomaviruses, vol 90. IARC Press, Lyon

  8. 8.

    De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124(7):1626–1636. https://doi.org/10.1002/ijc.24116

  9. 9.

    Murphy B (2017) Chief Medical Officer Letter - Changes to the National Cervical Screening Program (NCSP). http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/cmo-letter-changes-ncsp. Accessed 01 Apr 2019

  10. 10.

    Grant J (2017) Future Directions for HPV and Cervical Screening: Metro Auckland Cervical Screening Forum. Metro Auckland Cervical Screening Forum. http://nationalwomenshealth.adhb.govt.nz/Portals/0/CervicalScreening/EveningForums/MACSForum.June.2017.pdf. Accessed 24 Feb 2019

  11. 11.

    Roberts JR, Siekas LL, Kaz AM (2017) Anal intraepithelial neoplasia: a review of diagnosis and management. World J Gastrointest Oncol 9(2):50–61. https://doi.org/10.4251/wjgo.v9.i2.50

  12. 12.

    National Cancer Institute: Surveillance E, and End Results Program Cancer Stat Facts: Anal Cancer https://seer.cancer.gov/statfacts/html/anus.html. Accessed 17 Jun 2018

  13. 13.

    Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, Templeton DJ, Grulich AE (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13(5):487–500. https://doi.org/10.1016/s1470-2045(12)70080-3

  14. 14.

    Taylor S, Bunge E, Bakker M, Castellsague X (2016) The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infect Dis 16:293. https://doi.org/10.1186/s12879-016-1633-9

  15. 15.

    Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM (2001) Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 93(11):843–849

  16. 16.

    Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, Rogers K (1994) Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 81(3):365–367

  17. 17.

    Gautier M, Brochard C, Lion A, Henno S, Mallet AL, Bodere A, Bouguen G, Lievre A, Siproudhis L (2016) High-grade anal intraepithelial neoplasia: progression to invasive cancer is not a certainty. Dig Liver Dis 48(7):806–811. https://doi.org/10.1016/j.dld.2016.03.011

  18. 18.

    Long KC, Menon R, Bastawrous A, Billingham R (2016) Screening, surveillance, and treatment of anal intraepithelial neoplasia. Clin Colon Rectal Surg 29(1):57–64. https://doi.org/10.1055/s-0035-1570394

  19. 19.

    Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu X, Ning L, Killeen J, Kamemoto L, Goodman MT (2009) Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis 48(5):536–546. https://doi.org/10.1086/596758

  20. 20.

    Lee GC, Kunitake H, Milch H, Savitt LR, Stafford CE, Bordeianou LG, Francone TD, Ricciardi R (2018) What is the risk of anal carcinoma in patients with anal intraepithelial neoplasia III? Dis Colon Rectum 61(12):1350–1356. https://doi.org/10.1097/dcr.0000000000001219

  21. 21.

    Berry JM, Jay N, Cranston RD, Darragh TM, Holly EA, Welton ML, Palefsky JM (2014) Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer 134(5):1147–1155. https://doi.org/10.1002/ijc.28431

  22. 22.

    Scholefield JH, Castle MT, Watson NF (2005) Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 92(9):1133–1136. https://doi.org/10.1002/bjs.4994

  23. 23.

    Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, Berry JM, Jay N, Darragh TM (1998) Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 17(4):314–319

  24. 24.

    Patel HS, Silver AR, Northover JM (2007) Anal cancer in renal transplant patients. Int J Colorectal Dis 22(1):1–5. https://doi.org/10.1007/s00384-005-0023-3

  25. 25.

    Patel HS, Silver AR, Levine T, Williams G, Northover JM (2010) Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg 97(11):1716–1721. https://doi.org/10.1002/bjs.7218

  26. 26.

    Burgos J, Curran A, Tallada N, Guelar A, Navarro J, Landolfi S, Villar J, Crespo M, Ribera E, Falco V (2015) Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM. AIDS 29(6):695–702. https://doi.org/10.1097/qad.0000000000000603

  27. 27.

    de Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vezina S, Cote P, Macleod J, Allaire G, Hadjeres R, Franco EL, Coutlee F (2011) HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 52(9):1174–1181. https://doi.org/10.1093/cid/cir064

  28. 28.

    Crum-Cianflone NF, Hullsiek KH, Marconi VC, Ganesan A, Weintrob A, Barthel RV, Agan BK (2010) Anal cancers among HIV-infected persons: HAARt is not slowing rising incidence. AIDS 24(4):535–543. https://doi.org/10.1097/QAD.0b013e328331f6e2

  29. 29.

    Machalek DA, Jin F, Poynten IM, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE, on behalf of the Sst (2016) Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men. Papillomavirus Res 2:97–105. https://doi.org/10.1016/j.pvr.2016.05.003

  30. 30.

    Camus M, Lesage AC, Flejou JF, Hoyeau N, Atienza P, Etienney I (2015) Which lesions should be biopsied during high-resolution anoscopy? Prospective descriptive study of simple morphological criteria. J Low Genit Tract Dis 19(2):156–160. https://doi.org/10.1097/lgt.0000000000000064

  31. 31.

    Richel O, Hallensleben ND, Kreuter A, van Noesel CJ, Prins JM, de Vries HJ (2013) High-resolution anoscopy: clinical features of anal intraepithelial neoplasia in HIV-positive men. Dis Colon Rectum 56(11):1237–1242. https://doi.org/10.1097/DCR.0b013e3182a53568

  32. 32.

    Tomassi MJ, Abbas MA, Klaristenfeld DD (2019) Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience. Int J Colorectal Dis 34(1):47–54. https://doi.org/10.1007/s00384-018-3167-7

  33. 33.

    Cajas-Monson LC, Ramamoorthy SL, Cosman BC (2018) Expectant management of high-grade anal dysplasia in people with HIV: long-term data. Dis Colon Rectum 61(12):1357–1363. https://doi.org/10.1097/dcr.0000000000001180

  34. 34.

    Goldstone SE, Johnstone AA, Moshier EL (2014) Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer. Dis Colon Rectum 57(3):316–323. https://doi.org/10.1097/dcr.0000000000000058

  35. 35.

    Johnstone AA, Silvera R, Goldstone SE (2015) Targeted ablation of perianal high-grade dysplasia in men who have sex with men: an alternative to mapping and wide local excision. Dis Colon Rectum 58(1):45–52. https://doi.org/10.1097/dcr.0000000000000241

  36. 36.

    Berry JM, Palefsky JM, Jay N, Cheng S-C, Darragh TM, Chin-Hong PV (2009) Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 52(2):239–247. https://doi.org/10.1007/DCR.0b013e31819793d9

  37. 37.

    Factor SH, Cooperstein A, Pereira GA, Goldstone SE (2014) Are colon and rectal surgeons ready to screen for anal dysplasia? Results of a survey on attitudes and practice. Sex Transm Dis 41(4):246–253. https://doi.org/10.1097/olq.0000000000000105

  38. 38.

    Arain S, Walts AE, Thomas P, Bose S (2005) The Anal Pap Smear: cytomorphology of squamous intraepithelial lesions. Cytojournal 2(1):4. https://doi.org/10.1186/1742-6413-2-4

  39. 39.

    Fox PA, Seet JE, Stebbing J, Francis N, Barton SE, Strauss S, Allen-Mersh TG, Gazzard BG, Bower M (2005) The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect 81(2):142–146. https://doi.org/10.1136/sti.2003.008318

  40. 40.

    Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM (1997) Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 14(5):415–422

  41. 41.

    Machalek DA, Poynten IM, Jin F, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE (2016) A composite cytology-histology endpoint allows a more accurate estimate of anal high-grade squamous intraepithelial lesion prevalence. Cancer Epidemiol Biomark Prev 25(7):1134–1143. https://doi.org/10.1158/1055-9965.epi-15-1106

  42. 42.

    Panther LA, Wagner K, Proper J, Fugelso DK, Chatis PA, Weeden W, Nasser IA, Doweiko JP, Dezube BJ (2004) High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 38(10):1490–1492. https://doi.org/10.1086/383574

  43. 43.

    Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383(9916):524–532. https://doi.org/10.1016/s0140-6736(13)62218-7

  44. 44.

    Padilla-Espana L, Repiso-Jimenez JB, Fernandez-Sanchez F, Pereda T, Rivas-Ruiz F, Fernandez-Morano T, de la Torre-Lima J, Palma F, Redondo M, de Troya-Martin M (2016) Effectiveness of human papillomavirus genotyping for detection of high-grade anal intraepithelial neoplasia compared to anal cytology. Enferm Infecc Microbiol Clin 34(7):400–405. https://doi.org/10.1016/j.eimc.2016.02.003

  45. 45.

    Cheng SH, Wang CC, Chang SL, Chu FY, Hsueh YM (2015) Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus. Int J Clin Oncol 20(5):943–951. https://doi.org/10.1007/s10147-015-0804-9

  46. 46.

    Sambursky JA, Terlizzi JP, Goldstone SE (2018) Testing for human papillomavirus strains 16 and 18 helps predict the presence of anal high-grade squamous intraepithelial lesions. Dis Colon Rectum 61(12):1364–1371. https://doi.org/10.1097/dcr.0000000000001143

  47. 47.

    Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM (2000) Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 108(8):634–641

  48. 48.

    Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM (1999) The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281(19):1822–1829

  49. 49.

    Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR, PoBotCPGCotASo Colon, Surgeons R (2018) The American Society of Colon and Rectal Surgeons clinical practice guidelines for anal squamous cell cancers (Revised 2018). Dis Colon Rectum 61(7):755–774. https://doi.org/10.1097/dcr.0000000000001114

  50. 50.

    Fox PA, Nathan M, Francis N, Singh N, Weir J, Dixon G, Barton SE, Bower M (2010) A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod. AIDS 24(15):2331–2335. https://doi.org/10.1097/QAD.0b013e32833d466c

  51. 51.

    Richel O, de Vries HJ, van Noesel CJ, Dijkgraaf MG, Prins JM (2013) Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol 14(4):346–353. https://doi.org/10.1016/s1470-2045(13)70067-6

  52. 52.

    Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EI (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365(17):1576–1585. https://doi.org/10.1056/NEJMoa1010971

  53. 53.

    A5298 Protocol Team (2016) ACTG A5298: A phase 3 trial of the quadrivalent HPV vaccine in older HIV + Adults. In: Paper presented at the conference on retroviruses and opportunistic infections, Seattle, Washington,

  54. 54.

    Miltz A, Price H, Shahmanesh M, Copas A, Gilson R (2014) Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure. PLoS One 9(3):e90348. https://doi.org/10.1371/journal.pone.0090348

  55. 55.

    Swedish KA, Factor SH, Goldstone SE (2012) Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 54(7):891–898. https://doi.org/10.1093/cid/cir1036

  56. 56.

    Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB (2015) Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men. Clin Infect Dis 61(10):1527–1535. https://doi.org/10.1093/cid/civ628

Download references

Acknowledgements

The authors acknowledge pathologist, Dr Martin Whitehead for providing histopathology slides.

Author information

Correspondence to T. Chittleborough.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This paper is not based on a previous communication to a society or meeting.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chittleborough, T., Tapper, R., Eglinton, T. et al. Anal squamous intraepithelial lesions: an update and proposed management algorithm. Tech Coloproctol 24, 95–103 (2020). https://doi.org/10.1007/s10151-019-02133-4

Download citation

Keywords

  • Anal squamous intraepithelial lesion
  • Anal intraepithelial neoplasia
  • Human papilloma virus
  • Anal squamous cell carcinoma